Effects of synbiotic consumption on lipid profile in diabetic patients

Subject Areas :

Jafar Aldaghi ¹ , Ariyo Movahedi ²

1 - Department of Nutrition, Science and Research Branch, Islamic Azad University, Tehran, Iran
2 - Department of Nutrition, Science and Research Branch, Islamic Azad University, Tehran, Iran

Received: 2021-04-02 Accepted : 2021-04-02 Published : 2021-03-01

Keywords:

References:

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(1): 62–9.

2. WHO. World Health Organization: Health topics, Diabetes. 2014. http://www.who.int/topics/diabetes_mellitus/en/

3. IDF. International Diabetes Federation: IDF Diabetes Atlas. 2015. http://www.diabetesatlas.org/across-theglobe.

4. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiological Reviews. 2013;93(1):137-88.

5. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010;5(2): e9085.

6. Musso G, Gambino R, Cassader M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?. Diabetes Care. 2010;33(10):2277-84.

7. Ejtahed HS, Soroush AR, Angoorani P, Larijani B, Hasani-Ranjbar S. Gut microbiota as a target in the pathogenesis of metabolic disorders: A new approach to novel therapeutic agents. Hormone and Metabolic Research. 2016;48(6):349-58.

8. Kechagia M, Basoulis D, Konstantopoulou S, Dimitriadi D, Gyftopoulou K, Skarmoutsou N, et al. Health benefits of probiotics: a review. ISRN Nutrition 2013;2013:481651.

9. Vergin, F. Antibiotics and probiotics. Hipokrates. 1954;25:116–9.

10.  Food and Agriculture Organization of the United Nations, issuing body. World Health Organization, issuing body. Probiotics in food: health and nutritional properties and guidelines for evaluation. http://www.fao.org/3/a-a0512e.pdf.

11.  Markowiak P, Slizewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017;9(9):1021.

12.  Moroti C, Magri LFS, de Rezende Costa M, Cavallini DC, Sivieri K. Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids in Health and Disease. 2012;11(1):29.

13.  Kavitha K, Reddy AG, Reddy KK, Kumar CS, Boobalan G, Jayakanth K. Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats. Veterinary World. 2016;9(2):118.

14.  Rajkumar H, Kumar M, Das N, Kumar SN, Challa HR, Nagpal R. Effect of probiotic Lactobacillus salivarius UBL S22 and prebiotic fructo-oligosaccharide on serum lipids, inflammatory markers, insulin sensitivity, and gut bacteria in healthy young volunteers: a randomized controlled single-blind pilot study. Journal of Cardiovascular Pharmacology and Therapeutics. 2015;20(3):289–98.

15.  Asemi Z, Khorrami-Rad A, Alizadeh S-A, Shakeri H, Esmaillzadeh A. Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial. Clinical Nutrition. 2014;33(2):198–203.

16.  Nikbakht E, Khalesi S, Singh I, Williams LT, West NP, Colson N. Effect of probiotics and synbiotics on blood glucose: a systematic review and meta-analysis of controlled trials. European Journal of Nutrition. 2018;57(1):95–106.

17.  Eslamparast T, Zamani F, Hekmatdoost A, et al. Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study. British Journal of Nutrition. 2014;112(3):438–45.

18.  Tajadadi-Ebrahimi M, Bahmani F, Shakeri H, et al. Effects of daily consumption of synbiotic bread on insulin metabolism and serum high-sensitivity C-reactive protein among diabetic patients: a double-blind, randomized, controlled clinical trial. Annals of Nutrition and Metabolism. 2014;65(1):34–41.

19.  Shakeri H, Hadaegh H, Abedi F, Tajabadi-Ebrahimi M, Mazroii N, Ghandi Y, Asemi Z. Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes. Lipids. 2014;49(7):695–701.

20.  Asemi Z, Alizadeh S-A, Khorshidi A, Goli M, Esmaillzadeh A. Effects of beta-carotene fortified synbiotic food on metabolic control of patients with type 2 diabetes mellitus: A double-blind randomized cross-over controlled clinical trial. Clinical Nutrition. 2016;35(4):819-25.

21.  Ahmadi S, Jamilian M, Tajadadi-Ebrahimi M, Jafari P, Asemi Z. The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes: a randomised, double-blind, placebo-controlled trial. British Journal of Nutrition. 2016;116:1394–401.

22.  Tajabadi-Ebrahimi M, Sharifi N, Farrokhian A, Raygan F, Karamali F, Razzaghi R, Taheri S, Asemi Z. A randomized controlled clinical trial investigating the effect of synbiotic administration on markers of insulin metabolism and lipid profiles in overweight type 2 diabetic patients with coronary heart disease. Experimental and Clinical Endocrinology & Diabetes. 2016;125(01):21–7.

23.  Ebrahimi Z, Nasli-Esfahani E, Nadjarzade A, Mozaffarikhosravi H. Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial. Journal of Diabetes & Metabolic Disorders. 2017;16(1):23.

24.  Razmpoosh E, Javadi A, Ejtahed HS, Mirmiran P, Javadi M, Yousefinejad A, The effect of probiotic supplementation on glycemic control and lipid profile in patients with type 2 diabetes: A randomized placebo-controlled trial. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(1):175-82.

25.  Nabhani Z, Hezaveh S.J.G, Razmpoosh E, Asghari-Jafarabadi M, Gargari B. The effects of synbiotic supplementation on insulin resistance/sensitivity, lipid profile and total antioxidant capacity in women with gestational diabetes mellitus: a randomized double-blind placebo-controlled clinical trial. Diabetes Research and Clinical Practice. 2018;138:149-57.

26.  Soleimani A, Motamedzadeh A, Mojarrad MZ, Bahmani F, Amirani E, Ostadmohammadi V, Tajabadi-Ebrahimi M, Asemi Z. The effects of synbiotic supplementation on metabolic status in diabetic patients undergoing hemodialysis: A randomized, double-Blinded, placebo-controlled trial. Probiotics and Antimicrobial Proteins. 2019;11(4):1248–56.

27.  Zare Javid A, Aminzadeh M, Haghighi-zadeh M.H, Jamalvandi M. The Effects of synbiotic supplementation on glycemic status, lipid profile, and biomarkers of oxidative stress in type 1 diabetic patients: A placebo-controlled, double-blind, randomized clinical trial. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020;13: 607–17.

28.  Mohammadi H, Miraghajani M, Ghaedi E. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD. Critical Reviews in Food Science and Nutrition. 2019;59(15):2494-505.

29.  De Vrese M, Schrezenmeir AJ. Probiotics, prebiotics, and synbiotics.  Advances in Biochemical Engineering / Biotechnology. 2008;111:1-66.           

30.  Konstantinov SR, Smidt H, de Vos WM, Bruijns SC, Singh SK, Valence F, Molle D, Lortal S, Altermann E, Klaenhammer TR, Van Kooyk Y (2008) S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(49):19474–79.

31.  Ouwehand AC, Tiihonen K, Saarinen M, Putaala H, Rautonen N. Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. British Journal of Nutrition. 2008;101(3):367–75.

32.  Brubaker SW, Bonham KS, Zanoni I, Kagan JC. Innate immune pattern recognition: a cell biological perspective. Annual Review of Immunology. 2015;33:257–90.

33.  Dasu MR, Devaraj S, Park S, Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care. 2010;33(4):861–68.

34.  Kimoto H, Ohmomo S, Okamoto T. Cholesterol removal from media by Lactococci. Journal of Dairy Science. 2002;85(12):3182–3188.

35.  Lye H-S, Rusul G, Liong M-T. Removal of cholesterol by Lactobacilli via incorporation and conversion to coprostanol. J Dairy Sci. 2010;93(4):1383–92.

36.  Begley M, Hill C, Gahan CG. Bile salt hydrolase activity in probiotics. Applied and Environmental Microbiology. 2006;72(3):1729–38.

37.  Patel AK, Singhania RR, Pandey A, Chincholkar SB. Probiotic bile salt hydrolase: current developments and perspectives. Applied Biochemistry and Biotechnology. 2010;162(1):166–80. 

38.  De Preter V, Vanhoutte T, Huys G, Swings J, De Vuyst L, Rutgeerts P, Verbeke K. Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2007;292(1):358–68.

39.  Zhuang G, Liu X-M, Zhang Q-X, Tian F-W, Zhang H, Zhang H-P, Chen W. Research advances with regards to clinical outcome and potential mechanisms of the cholesterol-lowering effects of probiotics. Journal of Clinical Lipidology. 2012;7(5):501–7.

40.  Leung C, Rivera L, Furness JB, Angus PW. The role of the gut microbiota in NAFLD. Nature Reviews Gastroenterology & Hepatology. 2016;13(7):412.

41.  Lee J, Hong S-W, Rhee E-J, Lee W-Y. GLP-1 receptor agonist and non-alcoholic fatty liver disease. Diabetes & Metabolism Journal. 2012;36(4):262–7.

42.  Campbell JE, Drucker DJ (2013) Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metabolism. 2013;17(6):819–837.

43.  Wojdemann M, Wettergren A, Sternby B, Holst JJ, Larsen S, Rehfeld JF, Olsen O. Inhibition of human gastric lipase secretion by glucagon-like peptide-1. Digestive Diseases and Sciences. 1998;43(4):799–05.